Other OTC • USD
Eloxx Pharmaceuticals, Inc. (ELOX)
As of 11:12 AM EDT. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
19,288.0000
34,419.0000
66,018.0000
29,437.0000
Operating Income
-19,288.0000
-34,419.0000
-66,018.0000
-29,437.0000
Net Non Operating Interest Income Expense
-1,145.0000
-1,675.0000
-1,251.0000
-1,072.0000
Other Income Expense
-49.0000
29.0000
542.0000
-4,068.0000
Pretax Income
-20,482.0000
-36,065.0000
-66,727.0000
-34,577.0000
Net Income Common Stockholders
-20,482.0000
-36,065.0000
-66,727.0000
-34,577.0000
Diluted NI Available to Com Stockholders
-20,482.0000
-36,065.0000
-66,727.0000
-34,577.0000
Basic EPS
-8.88
-16.65
-38.15
-34.40
Diluted EPS
-8.88
-16.65
-38.15
-34.40
Basic Average Shares
2,324.7520
2,166.3110
1,749.0710
1,003.1230
Diluted Average Shares
2,324.7520
2,166.3110
1,749.0710
1,003.1230
Total Operating Income as Reported
-19,288.0000
-34,419.0000
-66,018.0000
-33,455.0000
Total Expenses
19,288.0000
34,419.0000
66,018.0000
29,437.0000
Net Income from Continuing & Discontinued Operation
-20,482.0000
-36,065.0000
-66,727.0000
-34,577.0000
Normalized Income
-20,593.0000
-36,017.0000
-67,269.0000
-30,509.0000
Interest Income
386.0000
274.0000
8.0000
337.0000
Interest Expense
1,531.0000
1,949.0000
1,259.0000
1,409.0000
Net Interest Income
-1,145.0000
-1,675.0000
-1,251.0000
-1,072.0000
EBIT
-18,951.0000
-34,116.0000
-65,468.0000
-33,168.0000
EBITDA
-18,214.0000
-33,421.0000
-64,508.0000
-32,597.0000
Reconciled Depreciation
737.0000
695.0000
960.0000
571.0000
Net Income from Continuing Operation Net Minority Interest
-20,482.0000
-36,065.0000
-66,727.0000
-34,577.0000
Total Unusual Items Excluding Goodwill
111.0000
-48.0000
542.0000
-4,068.0000
Total Unusual Items
111.0000
-48.0000
542.0000
-4,068.0000
Normalized EBITDA
-18,325.0000
-33,373.0000
-65,050.0000
-28,529.0000
12/31/2020 - 12/11/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LEXXW Lexaria Bioscience Corp.
0.9200
+13.58%
SNSE Sensei Biotherapeutics, Inc.
1.0100
+8.50%
CWBR CohBar, Inc.
0.9004
0.00%
NBSE NeuBase Therapeutics, Inc.
0.4345
+5.55%
EVLO Evelo Biosciences, Inc.
0.0425
-2.41%
QNRX Quoin Pharmaceuticals, Ltd.
0.6600
0.00%
1AE.SG argenx SE
344.30
+1.56%
ARTLW Artelo Biosciences, Inc.
0.0117
0.00%
ARMP Armata Pharmaceuticals, Inc.
2.5000
-0.40%
SABSW SAB Biotherapeutics, Inc.
0.0300
0.00%